Collins Makes a Case for NCATS

Jul 08, 2011

Translation of recent biological discoveries into clinical applications has been plagued by "long timelines, steep costs, and high failure rates," writes National Institutes of Health Director Francis Collins in a commentary in Science Translational Medicine.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

Oncocyte AACR Data Expands Potential Applications for Immunotherapy Response Predictor
Proteomic Study of SARS-CoV-2, SARS-CoV Infections Points to Potential Drug Targets
HudsonAlpha Health Alliance, Auburn University Form Genetic Testing Partnership
Amazon to Give Out $12M Under Next Phase of AWS Diagnostics Development Initiative
Sandler Initiates Coverage of Twist Bioscience, Codexis With Overweight Ratings
Top Five Articles on GenomeWeb Last Week: Invitae, Cancer, Illumina, and More

The Scan

Early Trial Responses

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Hurdles to Genomic Surveillance

Nature News writes that viral genomic surveillance in the US faces systemic issues.

Boosts Requested

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

PLOS Papers on Chronic Pain, Indigenous Populations in Mexico, SARS-CoV-2 Mutations

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.

Menu